Ikonisys S.A. (ALIKO.PA)

EUR 1.47

(8.09%)

Market Cap (In EUR)

15.25 Million

Revenue (In EUR)

448.55 Thousand

Net Income (In EUR)

-2.26 Million

Avg. Volume

8561.00

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.25-1.8
PE
-
EPS
-
Beta Value
0.696
ISIN
FR00140048X2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Mario P. Crovetto
Employee Count
-
Website
https://www.ikonisys.com
Ipo Date
2021-07-19
Details
Ikonisys S.A., a cell based diagnostics company, engages in the design, manufacturing, marketing, and sale of medical diagnostic products for various cancers in the United States and Europe. It offers Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, and real-time image capture and analysis, and eliminates various factors that cause human error in testing; oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; and oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of rearrangements of the gene encoding anaplastic lymphoma kinase (ALK). The company also provides oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer CS, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; Ikonisoft explorer tissue, a FISH scanning application for analysis of various tissue section hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. Ikonisys S.A. is based in Paris, France.